To begin with, Charles River Laboratories International seems to have a respectable ROE. And on comparing with the industry, we found that the the average industry ROE is similar at 12%. This ...

Evercore ISI analyst Elizabeth Anderson CFA maintained a Buy rating on Charles River Labs (CRL – Research Report) today and set a price ...

After several years spent honing its robotic cell therapy manufacturing system, Multiply Labs has snared its first ...

A nonprofit group recently ran a billboard campaign targeting the Western Michigan University Homer Stryker M.D. School of Medicine.

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $218.3, with a ...

For Q2 2024, the Voya MidCap Opportunities Strategy underperformed its benchmark on a NAV basis due to unfavorable allocation ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...

“Digital twins” refer to simulations that help drug developers and others understand how a theoretical situation might play ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

With the launch of Casgevy gaining momentum, Vertex Pharmaceuticals is adding another link to its gene-editing therapy supply ...